Literature DB >> 8741392

What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis?

H Ichikawa1, Y Nagake, M Takahashi, H Nakazono, K Kawabata, K Shikata, H Makino.   

Abstract

Since red blood cell survival time is shortened in patients with diabetes mellitus (DM) on hemodialysis (HD), it is unlikely that indices of glycemic control accurately reflect the glycemic state of these individuals. In this study, in order to determine the best index of glycemic control in diabetic patients on HD, we measured HbAlc, 1,5-anhydroglucitol (1,5-AG), fructosamine (Fr) and glycated albumin (GA) in 31 diabetic patients on HD (20 males and 11 females, mean age: 66.9 years), and examined the correlation between each index and predialysis plasma glucose level. Since the mean values of predialysis plasma glucose during the final 2 and 4 weeks before the study were best correlated with HbAlc, this parameter was considered to be the most reliable index of glycemic control in diabetic patients on HD. GA was more closely correlated with mean values of predialysis plasma glucose during the final 2 and 4 weeks, than any other index of glycemic control, followed by HbAlc. In conclusion, HbAlc is considered to be the most reliable index of glycemic control in diabetic patients on HD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741392

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN: 0385-2385


  11 in total

Review 1.  Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Dragana Lovre; Sulay Shah; Aanu Sihota; Vivian A Fonseca
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12-18       Impact factor: 4.741

Review 2.  Update on glycemic control for the treatment of diabetic kidney disease.

Authors:  Girish N Nadkarni; Rabi Yacoub; Steven G Coca
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

Review 3.  Glycemic control and burnt-out diabetes in ESRD.

Authors:  Csaba P Kovesdy; Jong C Park; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2010-03-30       Impact factor: 3.455

4.  Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction.

Authors:  Won Jun Kim; Cheol-Young Park; Kyu-Beck Lee; Se Eun Park; Eun Jung Rhee; Won Young Lee; Ki Won Oh; Sung Woo Park
Journal:  Diabetes Care       Date:  2011-12-30       Impact factor: 19.112

5.  Raman spectroscopy provides a powerful diagnostic tool for accurate determination of albumin glycation.

Authors:  Narahara Chari Dingari; Gary L Horowitz; Jeon Woong Kang; Ramachandra R Dasari; Ishan Barman
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

Review 6.  Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease.

Authors:  Frederiek E Vos; John B Schollum; Robert J Walker
Journal:  NDT Plus       Date:  2011-12

7.  Chapter 3: Management of progression and complications of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

8.  Chapter 5: Referral to specialists and models of care.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

Review 9.  Glycated Albumin Versus HbA1c in the Evaluation of Glycemic Control in Patients With Diabetes and CKD.

Authors:  Ting Gan; Xin Liu; Gaosi Xu
Journal:  Kidney Int Rep       Date:  2017-11-21

10.  Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients.

Authors:  Tariq Shafi; Stephen M Sozio; Laura C Plantinga; Bernard G Jaar; Edward T Kim; Rulan S Parekh; Michael W Steffes; Neil R Powe; Josef Coresh; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2012-12-18       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.